CTT Pharmaceutical CEO Ryan Khouri reports purchase of 7,700 shares for $500.5
CTTH•CEO buys 7,700 shares
- CTT Pharmaceutical’s CEO Ryan Khouri bought 7,700 CTTH shares at USD 0.07 each.
- Directly held stake increased to 9,353,656 shares following the purchase.
